Skip to main content
Premium Trial:

Request an Annual Quote

Informax to Integrate Biomax Data Retrieval System into Platform

NEW YORK, Jan 16 - Informax has inked a four-year deal with Biomax of Martinsreid, Germany, to add Biomax’s BioRS data integration and retrieval system to the Informax platform, and to market and distribute BioRS around the world, the companies announced Tuesday.

BioRS integrates public and proprietary biological databases through a web interface. This tool provides Informax with a highly scalable way to integrate data across its bioinformatics applications, according to Stephen Lincoln, Informax’s senior vice president of life science informatics.

" These tools will drive the increasing productivity of biomedical R&D worldwide by integrating large genomic and proteomic databases with powerful gene function analysis to bring the power of leading edge genome-based discovery techniques to bear on day to day laboratory bench experimentation across the industry,” Lincoln said in a statement.

Through hitching its wagon to Informax, Biomax can gain access to Informax’s customer base of over 500 organizations throughout Europe, 150 of which are in Germany.

“This agreement furthers our commitment to remain the leading bioinformatics solutions provider in the U.S., Europe, and globally," Informax CEO Alex Titomirov said in a statement. " BioRS has been adopted as the sequence retrieval system of choice by the majority of the pharmaceutical companies in Germany. Together, BioRS and our GenoMax and Vector NTI platforms will constitute the most comprehensive solution available today to address the well-known problems of information overload in biological research."

The companies did not disclose the financial terms of the agreement.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.